News
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...
Recommendation of first chikungunya vaccine for persons as ... COPENHAGEN, Denmark, April 16, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control ...
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark, ...
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark ...
Paul Chaplin, President and CEO of Bavarian Nordic said:“The ACIP's recommendation of our chikungunya vaccine for Americans aged 12 and older is a big step forward to expanding access to this ...
The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.
Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results